Xinfeng "Charlie" Zhang

Sr. Vice President, CMC at Akeso, Inc. 康方生物医药有限公司
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
San Francisco Bay Area
Skills

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Experience

  • Akeso, Inc. 康方生物医药有限公司
    • Sr. Vice President, CMC
      • 2020 - Present
  • I-Mab Biopharma
    • China
    • Biotechnology
    • 1 - 100 Employee
    • Sr. Vice President, CMC Operation and Regulatory
      • 2019 - 2020
  • Generon BioMed Holding Ltd.
    • Head of Global CMC Operation / Corporate Strategy
      • 2017 - 2019

      Global Corporate Strategy Development; Commercial BioPharmaceutical manufacturing and supply chain operation; Contract manufacturing operation management in US and EU Global Corporate Strategy Development; Commercial BioPharmaceutical manufacturing and supply chain operation; Contract manufacturing operation management in US and EU

  • Generon Biopharmaceutical Beijing Co., Ltd.
    • Founding General Manager
      • 2013 - 2017

      Design, commissioning and operation of biologics manufacturing facility; Manufacture and release of Drug Substance and Drug Product for Phase III clinical trials in US, EU and China; Global regulatory filing Design, commissioning and operation of biologics manufacturing facility; Manufacture and release of Drug Substance and Drug Product for Phase III clinical trials in US, EU and China; Global regulatory filing

  • Generon (Shanghai) Corporation
    • Biotechnology Research
    • 1 - 100 Employee
    • Vice President, Chemistry, Manufacturing and Controls (CMC)
      • 2012 - 2015

      Development, manufacture and release of Biologics Products from pre-clinical to Phase II clinical stage; Global regulatory filing to US, EU and China Development, manufacture and release of Biologics Products from pre-clinical to Phase II clinical stage; Global regulatory filing to US, EU and China

  • Boehringer Ingelheim (formerly Amgen Fremont)
    • Lab Head, Process Science
      • 2011 - 2012
  • Amgen
    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Senior Scientist, Process and Product Engineering
      • 2007 - 2011
  • PDL BioPharma (Acquired by Abbvie)
    • Scientist II, Process Development
      • 2006 - 2007
  • Novartis AG (Chiron Corp.)
    • Scientist, Process and Product Development
      • 2003 - 2006

Education

  • Peking University
    Bachelor of Science (BS), Chemistry
  • University of Rhode Island
    Doctor of Philosophy (Ph.D.), Chemistry

Community

You need to have a working account to view this content. Click here to join now